These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1933161)

  • 21. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
    Bell DS; Cutter GR; Hayne VB; Lloyd LK
    Urology; 1992 Jul; 40(1):36-40. PubMed ID: 1621310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
    Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
    J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
    Katlowitz N; Albano GJ; Patsias G; Golimbu M; Morales P
    Urology; 1993 Dec; 42(6):695-7. PubMed ID: 8256402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penile self-injection for impotence in patients after radical cystectomy-ileal loop.
    Al-Juburi AZ; O'Donnell PD
    Urology; 1987 Jul; 30(1):29-30. PubMed ID: 3603906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracorporal injection of papaverine and phentolamine in the management of impotence.
    Robinette MA; Moffat MJ
    Br J Urol; 1986 Dec; 58(6):692-5. PubMed ID: 3801830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks of self-injection therapy for impotence.
    Millard RJ; Stricker PD; Lynch WJ; Dean TE; Murnaghan GF; Breslin FH
    Med J Aust; 1996 Jul; 165(2):117-8. PubMed ID: 8692055
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologically induced erections among geriatric men.
    Kerfoot WW; Carson CC
    J Urol; 1991 Oct; 146(4):1022-4. PubMed ID: 1895417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Penile self-injection of a papaverine-phentolamine combination, as treatment of impotence, in patients treated with radical cystoprostatectomy].
    Calahorra Fernández FJ; Rodríguez A; Castro M; Tamayo JC; Alvarez E; Leiva O
    Actas Urol Esp; 1991; 15(1):43-5. PubMed ID: 2058441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracavernosal injection and intraurethral therapy for erectile dysfunction.
    Leungwattanakij S; Flynn V; Hellstrom WJ
    Urol Clin North Am; 2001 May; 28(2):343-54. PubMed ID: 11402586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary report of a new concept in the pharmacological treatment of erectile impotence using an implantable drug delivery system.
    Desai KM; Gingell JC; Floyd TJ
    Br J Urol; 1987 Sep; 60(3):267-70. PubMed ID: 3676676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
    Montorsi F; Guazzoni G; Bergamaschi F; Orlandini A; Da Pozzo L; Barbieri L; Rigatti P
    J Urol; 1993 Dec; 150(6):1829-32. PubMed ID: 7693979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.